Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Invitrogen (IVGN)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for IVGN as compared to
Top Competitors
Acquired
Biotechnology
Exclude From Rankings
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
1.42B
EBITDA
►
395M
Net Income
►
179M
Revenue Growth
►
11.1%
Net Income Growth
►
8924.7%
Operating Margin
►
19%
Net Margin
►
12.5%
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.844
Current Ratio
►
4.71
Quick Ratio
►
3.86
Interest Coverage Ratio
►
9.73
Book Value Per Share
►
15.7
Cash Per Share
►
5.77
Loading...
STOCK SUMMARY
Open
0.00
Day Range
27.25
-
28.28
52 Week Range
19.56
-
48.13
Volume
0
Avg Volume (3 mo)
3.55M
Shares Outstanding
105M
Market Cap
2.61B
VALUATION
Price to Earnings (P/E)
►
14.7
Price to Book (P/B)
►
1.41
Price to Sales (P/S)
►
1.84
Return on Assets (ROA)
►
6.2%
Return on Equity (ROE)
►
10.1%
EV/EBITDA
►
11.2
Dividend Yield
0%
OWNERSHIP
Net Insider Buying 3mo
-17.5%
Net Insider Buying 6mo
-20.3%
Net Insider Buying 1yr
-20.8%
Held by insiders
1.6%
Held by institutions
0%
No Sales Breakout Data.